CovidChloroV1, Main, Corpus, bibRecord, 001804

COVID-19 and Depression.

Identifieur interne : 001804 ( Main/Corpus ); précédent : 001803; suivant : 001805

COVID-19 and Depression.

Auteurs : Richard I. Shader

Source :

Clinical therapeutics [ 1879-114X ] ; 2020.

RBID : pubmed:32362345

English descriptors

KwdEn :
- Anxiety (diagnosis), Anxiety (psychology), Betacoronavirus (pathogenicity), COVID-19 (MeSH), Chloroquine (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Coronavirus Infections (psychology), Depression (diagnosis), Depression (psychology), Humans (MeSH), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Pneumonia, Viral (psychology), SARS-CoV-2 (MeSH), Unemployment (psychology).
MESH :
- chemical , therapeutic use : Chloroquine, Hydroxychloroquine.
- diagnosis : Anxiety, Depression.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- psychology : Anxiety, Coronavirus Infections, Depression, Pneumonia, Viral, Unemployment.
- COVID-19, Humans, Pandemics, SARS-CoV-2.

Abstract

The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use chloroquine and hydroxychloroquine in patients with COVID-19.

DOI: 10.1016/j.clinthera.2020.04.010
PubMed: 32362345
PubMed Central: PMC7184005

Links to Exploration step

pubmed:32362345

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and Depression.</title>
<author><name sortKey="Shader, Richard I" sort="Shader, Richard I" uniqKey="Shader R" first="Richard I" last="Shader">Richard I. Shader</name>
<affiliation><nlm:affiliation>Tufts University School of Medicine, Boston, MA, United States. Electronic address: Richard.Shader@tufts.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32362345</idno>
<idno type="pmid">32362345</idno>
<idno type="doi">10.1016/j.clinthera.2020.04.010</idno>
<idno type="pmc">PMC7184005</idno>
<idno type="wicri:Area/Main/Corpus">001804</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001804</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and Depression.</title>
<author><name sortKey="Shader, Richard I" sort="Shader, Richard I" uniqKey="Shader R" first="Richard I" last="Shader">Richard I. Shader</name>
<affiliation><nlm:affiliation>Tufts University School of Medicine, Boston, MA, United States. Electronic address: Richard.Shader@tufts.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical therapeutics</title>
<idno type="eISSN">1879-114X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anxiety (diagnosis)</term>
<term>Anxiety (psychology)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>COVID-19 (MeSH)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (psychology)</term>
<term>Depression (diagnosis)</term>
<term>Depression (psychology)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (psychology)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Unemployment (psychology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Anxiety</term>
<term>Depression</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Anxiety</term>
<term>Coronavirus Infections</term>
<term>Depression</term>
<term>Pneumonia, Viral</term>
<term>Unemployment</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use chloroquine and hydroxychloroquine in patients with COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32362345</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-114X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>42</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>Clinical therapeutics</Title>
<ISOAbbreviation>Clin Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>COVID-19 and Depression.</ArticleTitle>
<Pagination><MedlinePgn>962-963</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0149-2918(20)30198-3</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinthera.2020.04.010</ELocationID>
<Abstract><AbstractText>The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use chloroquine and hydroxychloroquine in patients with COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shader</LastName>
<ForeName>Richard I</ForeName>
<Initials>RI</Initials>
<AffiliationInfo><Affiliation>Tufts University School of Medicine, Boston, MA, United States. Electronic address: Richard.Shader@tufts.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Clin Ther</MedlineTA>
<NlmUniqueID>7706726</NlmUniqueID>
<ISSNLinking>0149-2918</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014478" MajorTopicYN="N">Unemployment</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Chloroquine</Keyword>
<Keyword MajorTopicYN="Y">Demoralization</Keyword>
<Keyword MajorTopicYN="Y">Depression</Keyword>
<Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32362345</ArticleId>
<ArticleId IdType="pii">S0149-2918(20)30198-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.clinthera.2020.04.010</ArticleId>
<ArticleId IdType="pmc">PMC7184005</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Compr Psychiatry. 1993 Sep-Oct;34(5):308-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8306640</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Ther. 2014 Nov 1;36(11):1483-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25455928</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 1974 Mar;131(3):271-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4812687</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Perspect Biol Med. 1971 Winter;14(2):290-300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5546254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychopharmacol. 1982 Feb;2(1):40-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7040501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Psychopharmacol. 2005 Aug;25(4):291-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16012269</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001804 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001804 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32362345
   |texte=   COVID-19 and Depression.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32362345" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

COVID-19 and Depression.

COVID-19 and Depression.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki